As of Feb 27
| -0.31 / -0.40%|
The 2 analysts offering 12-month price forecasts for China Biologic Products Inc have a median target of 88.20, with a high estimate of 96.40 and a low estimate of 80.00. The median estimate represents a +15.14% increase from the last price of 76.60.
The current consensus among 2 polled investment analysts is to Buy stock in China Biologic Products Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.